SCHEMBL28575832

SCHEMBL28575832

O=C(O)CN1CCCN(c2ccc(CCl)cc2)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
CYP2D6 P10635 3/20 0.48
CYP2C19 P33261 3/20 0.48
CYP2C9 P11712 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.43
S1PR1 P21453 1/20 0.42
HDAC1 Q13547 7/20 0.41
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 2/20 0.39
RECQL P46063 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DRD2 P14416 2/20 0.37
DRD3 P35462 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28583263 0.87 LMNA (0.46) LMNACYP2D6CYP2C19CYP2C9KMT2A
SCHEMBL21594999 0.77 S1PR1 (0.40) LMNARAB9AS1PR1HDAC1ALDH1A1
SCHEMBL7283544 0.76 F10 (0.51)
SCHEMBL21594874 0.75 RAB9A (0.42) KMT2ARAB9AS1PR1HDAC1DRD2
SCHEMBL3582057 0.74 KMT2A (0.61) LMNACYP2D6CYP2C19CYP2C9KMT2A
SCHEMBL12038114 0.71 S1PR1 (0.78) LMNACYP2D6CYP2C19CYP2C9KMT2A
SCHEMBL2964066 0.71 DRD2 (0.57) LMNACYP2D6CYP2C19CYP2C9KMT2A
SCHEMBL12275459 0.70 FFAR4 (0.48) CYP2D6CYP2C19CYP2C9KMT2APOLB
SCHEMBL7401407 0.69 ITGB3 (0.50) HDAC1
SCHEMBL21770514 0.69 ALDH1A1 (0.53) LMNAKMT2APOLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112888696-B Exonuclease inhibitors and methods of use thereof 德琪医疗有限公司 2024-04-16 CN disclosed
CN-112888696-A Exonucleotidase inhibitors and methods of use thereof 卡利泰拉生物科技公司 2021-06-01 CN disclosed